Revascularization in systolic heart failure: A difficult decision

Circulation

Volumn 113, Issue 2, 2006, Pages 180-182

  Gibbons, Raymond J ^a   Chareonthaitawee, Panithaya ^a   Bailey, Kent R ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Editorials; Heart failure; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; FLUORODEOXYGLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RUBIDIUM 82;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART TRANSPLANTATION; HEART VALVE SURGERY; HUMAN; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYOCARDIAL HIBERNATION; ORAL GLUCOSE TOLERANCE TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; SYSTOLIC HEART FAILURE; CONGESTIVE HEART FAILURE; META ANALYSIS; NOTE; SYSTOLE; TREATMENT OUTCOME;

HEART FAILURE, CONGESTIVE; HUMANS; META-ANALYSIS; MYOCARDIAL REVASCULARIZATION; SYSTOLE; TREATMENT OUTCOME;

EID: 33644991425     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.595462     Document Type: Editorial

References (13)

1. Chareonthaitawee P, Gersh BJ, Araoz PA, Gibbons RJ. Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol. 2005;46:567-574.
2. Tarakji KG, Branken R, McCarthy PM, Al-Chekakie MO, Abdel-Latif A, Pothier CE, Blackstone EH, Lauer MS. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation. 2006;113:230-237.
3. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular systolic dysfunction: a metaanalysis. J Am Coll Cardiol. 2002;39:1151-1158.
4. Desideri A, Cortigiani L, Christen AI, Coscarelli S, Gregori D, Zanco P, Komorovsky R, Bax JJ. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol. 2005;46:1264-1269.
5. Knuuti J, Schelbert HR, Bax JJ. The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction. Eur J Nucl Med. 2002;29:1257-1266.
6. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina). Available at: http://www.acc.org/clinical/guidelines/stable/stable_clean.pdf. Accessed December 30, 2005.
7. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Available at: http://www.acc. org/clinical/guidelines/ cabg/index.pdf. Accessed December 30, 2005.
8. Holmes DR Jr, Davis KB, Mock MB, Fisher LD, Gersh BJ, Killip T 3rd, Pettinger M. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation. 1986;73:1254-1263.
9. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352:222-224.
10. Hunt SA, Abrahan WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup ML, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure. Available at: http://www.acc.org/clinical/guidelines/failure/ update/index.pdf. Accessed December 30, 2005.
11. Cleland JG, Freemantle N, Ball SG, Bonser RS, Camici P, Chattopadhyay S, Dutka D, Eastaugh J, Hampton J, Large S, Norell MS, Pennell DJ, Pepper J, Sanda S, Senior R, Smith D. The Heart Failure Revascularisation Trial (HEART): rationale, design and methodology. Eur J Heart Fail. 2003;5:295-303.
12. Joyce D, Loebe M, Noon GP, McRee S, Southard R, Thompson L, Skrabal C, Youker K, Torre-Amione G. Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial. Curr Opin Cardiol. 2003;18:454-457.
13. Beanlands R, Nichol G, Ruddy TD, deKemp RA, Hendry P, Humen D, Racine N, Ross H, Benard F, Coats G, Iwanochko RM, Fallen E, Wells G, for the PARR-2 Investigators. Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rational, design, and methods. Control Clin Trials. 2003;24: 776-794.